107 related articles for article (PubMed ID: 14602801)
21. Four polymorphisms of the CAPN 10 gene and their relationship to polycystic ovary syndrome susceptibility: a meta-analysis.
Huang M; Xiao J; Zhao X; Liu C; Chen Q
Clin Endocrinol (Oxf); 2012 Mar; 76(3):431-8. PubMed ID: 21906115
[TBL] [Abstract][Full Text] [Related]
22. Association of the 17-hydroxysteroid dehydrogenase type 5 gene polymorphism (-71A/G HSD17B5 SNP) with hyperandrogenemia in polycystic ovary syndrome (PCOS).
Marioli DJ; Saltamavros AD; Vervita V; Koika V; Adonakis G; Decavalas G; Markou KB; Georgopoulos NA
Fertil Steril; 2009 Aug; 92(2):648-52. PubMed ID: 18692800
[TBL] [Abstract][Full Text] [Related]
23. [Association of the calpain-10 gene polymorphism with glucose metabolism disorder in pregnant women].
Wu HR; Yang HX
Zhonghua Fu Chan Ke Za Zhi; 2009 Mar; 44(3):183-7. PubMed ID: 19570442
[TBL] [Abstract][Full Text] [Related]
24. The role of epistasis in the etiology of Polycystic Ovary Syndrome among Indian women: SNP-SNP and SNP-environment interactions.
Dasgupta S; Reddy BM
Ann Hum Genet; 2013 Jul; 77(4):288-98. PubMed ID: 23550965
[TBL] [Abstract][Full Text] [Related]
25. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.
Diamanti-Kandarakis E; Kouli CR; Bergiele AT; Filandra FA; Tsianateli TC; Spina GG; Zapanti ED; Bartzis MI
J Clin Endocrinol Metab; 1999 Nov; 84(11):4006-11. PubMed ID: 10566641
[TBL] [Abstract][Full Text] [Related]
26. Characteristics of different phenotypes of polycystic ovary syndrome based on the Rotterdam criteria in the Croatian population.
Baldani DP; Skrgatić L; Simunić V; Zlopasa G; Canić T; Trgovcić I
Coll Antropol; 2013 Jun; 37(2):477-82. PubMed ID: 23940993
[TBL] [Abstract][Full Text] [Related]
27. Calpain-10 genetic polymorphisms and polycystic ovary syndrome risk: a meta-analysis and meta-regression.
Shen W; Li T; Hu Y; Liu H; Song M
Gene; 2013 Dec; 531(2):426-34. PubMed ID: 23994294
[TBL] [Abstract][Full Text] [Related]
28. Variants in SULT2A1 affect the DHEA sulphate to DHEA ratio in patients with polycystic ovary syndrome but not the hyperandrogenic phenotype.
Louwers YV; de Jong FH; van Herwaarden NA; Stolk L; Fauser BC; Uitterlinden AG; Laven JS
J Clin Endocrinol Metab; 2013 Sep; 98(9):3848-55. PubMed ID: 23861462
[TBL] [Abstract][Full Text] [Related]
29. Polycystic ovary syndrome: a common but often unrecognized condition.
Shannon M; Wang Y
J Midwifery Womens Health; 2012; 57(3):221-30. PubMed ID: 22594862
[TBL] [Abstract][Full Text] [Related]
30. Comment: the methionine 196 arginine polymorphism in exon 6 of the TNF receptor 2 gene (TNFRSF1B) is associated with the polycystic ovary syndrome and hyperandrogenism.
Peral B; San Millán JL; Castello R; Moghetti P; Escobar-Morreale HF
J Clin Endocrinol Metab; 2002 Aug; 87(8):3977-83. PubMed ID: 12161545
[TBL] [Abstract][Full Text] [Related]
31. The genetics of the polycystic ovary syndrome.
Urbanek M
Nat Clin Pract Endocrinol Metab; 2007 Feb; 3(2):103-11. PubMed ID: 17237837
[TBL] [Abstract][Full Text] [Related]
32. Common polymorphisms of calpain-10 and the risk of Type 2 Diabetes in a Tunisian Arab population: a case-control study.
Ezzidi I; Turki A; Messaoudi S; Chaieb M; Kacem M; Al-Khateeb GM; Mahjoub T; Almawi WY; Mtiraoui N
BMC Med Genet; 2010 May; 11():75. PubMed ID: 20470430
[TBL] [Abstract][Full Text] [Related]
33. Polycystic ovaries are inherited as an autosomal dominant trait: analysis of 29 polycystic ovary syndrome and 10 control families.
Govind A; Obhrai MS; Clayton RN
J Clin Endocrinol Metab; 1999 Jan; 84(1):38-43. PubMed ID: 9920059
[TBL] [Abstract][Full Text] [Related]
34. A meta-analysis of polycystic ovary syndrome in women taking valproate for epilepsy.
Hu X; Wang J; Dong W; Fang Q; Hu L; Liu C
Epilepsy Res; 2011 Nov; 97(1-2):73-82. PubMed ID: 21820873
[TBL] [Abstract][Full Text] [Related]
35. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
Hassa H; Tanir HM; Yildiz Z
Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
[TBL] [Abstract][Full Text] [Related]
36. Is hyperandrogenemia protective for fibrocystic breast disease in PCOS?
Ozkaya E; Cakir E; Cinar M; Kara F; Baser E; Cakir C; Kucukozkan T
Gynecol Endocrinol; 2012 Jun; 28(6):468-71. PubMed ID: 22103710
[TBL] [Abstract][Full Text] [Related]
37. DENND1A gene variants in Bahraini Arab women with polycystic ovary syndrome.
Gammoh E; Arekat MR; Saldhana FL; Madan S; Ebrahim BH; Almawi WY
Gene; 2015 Apr; 560(1):30-3. PubMed ID: 25626177
[TBL] [Abstract][Full Text] [Related]
38. Association between β2-adrenoceptor (ADRB2) haplotypes and insulin resistance in PCOS.
Tellechea ML; Muzzio DO; Iglesias Molli AE; Belli SH; Graffigna MN; Levalle OA; Frechtel GD; Cerrone GE
Clin Endocrinol (Oxf); 2013 Apr; 78(4):600-6. PubMed ID: 22900502
[TBL] [Abstract][Full Text] [Related]
39. The CAPN10 gene is associated with insulin resistance phenotypes in the Spanish population.
Sáez ME; González-Sánchez JL; Ramírez-Lorca R; Martínez-Larrad MT; Zabena C; González A; Morón FJ; Ruiz A; Serrano-Ríos M
PLoS One; 2008 Aug; 3(8):e2953. PubMed ID: 18698425
[TBL] [Abstract][Full Text] [Related]
40. Genetic polymorphisms of GnRH and gonadotrophic hormone receptors affect the phenotype of polycystic ovary syndrome.
Valkenburg O; Uitterlinden AG; Piersma D; Hofman A; Themmen AP; de Jong FH; Fauser BC; Laven JS
Hum Reprod; 2009 Aug; 24(8):2014-22. PubMed ID: 19403562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
